Advances in Zoonotic and Tick-Borne Viruses

Dear Colleagues,

Recent years have seen substantial advances in understanding, preventing, and managing zoonotic and tick-borne viruses, critical to addressing pressing public health concerns. Zoonotic viruses often emerge from animal populations and spread to humans due to increased human–animal interaction, urbanization, and habitat encroachment, leading to novel infections and potential outbreaks. Tick-borne viruses, transmitted through tick bites, further pose a range of diseases, from Lyme disease to Zika, Ebola, and Crimean–Congo hemorrhagic fever, impacting human health significantly. The globalization of travel and trade facilitates rapid viral spread across borders, accentuating the need for adequate containment and control strategies. Some zoonotic viruses, as exemplified by the ongoing COVID-19 pandemic, possess pandemic potential due to their high transmissibility and substantial morbidity and mortality rates.

Additionally, changes in climate and ecological patterns influence disease vectors such as ticks, altering disease spread and exposing new populations. Inadequate surveillance and limited preparedness exacerbate the impact of outbreaks, especially on vulnerable populations lacking adequate healthcare access. Addressing these pressing issues requires a comprehensive and interdisciplinary approach involving enhanced surveillance, research on host–virus interactions, sustainable land use practices, improved healthcare infrastructure, public education, and international collaboration to mitigate the impact of zoonotic and tick-borne viruses on global health. Vaccine, immunotherapeutic, advanced diagnostic, and vector control strategies have demonstrated notable progress in recent years, emphasizing the importance of sustained research and collaboration to combat zoonotic and tick-borne viruses and ensure global health security.

Dr. Nigel Aminake Makoah
Dr. Thomas Tipih
Dr. Hussein Abkallo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• zoonotic viruses
• tick-borne viruses
• public health
• disease outbreaks
• surveillance
• preparedness
• vaccine
• immunotherapeutic
• advanced diagnostics
• vector control strategies